Skip to main content

Hidradenitis Suppurativa clinical trials at UCSD

1 research study open to eligible people

Showing trials for
  • Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

    open to all eligible people

    TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

    San Diego, California and other locations

Our lead scientists for Hidradenitis Suppurativa research studies include .

Last updated: